GENE ONLINE|News &
Opinion
Blog

LATEST
Special Dementia
Combination of Essential Amino Acids Prevents Brain Atrophy in Dementia
2021-10-31
Can Regulations Measure up to the Progress of Precision Medicine in Taiwan? – An Interview With Dr. Johnsee Lee
2021-10-30
Trials & Approvals Alzheimer's Disease
Cortexyme’s Shares Implode after Alzheimer’s Disease Drug Flunks Trial
2021-10-29
Asia-Pacific Decentralized Trial
Are Decentralized Clinical Trials Taking Root in Japan?
2021-10-29
Policy Rare Disease
Big Pharma and Non-Profits Join NIH, FDA in New Rare Diseases Drive
2021-10-28
Special Prime Editing
New Age Gene Editors Take Us Closer to CRISPR-Based Gene Therapy
2021-10-28
Asia-Pacific COVID-19
South Korea Approves EUA for Moderna’s COVID-19 Vaccine Produced by Samsung Biologics
2021-10-28
M&A Cell Therapy
Takeda Snags UK-Based Cell Therapy Collaborator to Boost Immuno-Oncology Portfolio
2021-10-27
Funding Cell Therapy
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
China Cancer
Angel Pharma Pushes First-In-Class ITK Inhibitor into Trial in China
2021-10-27
Licensing CRISPR
Vertex Signs $700 Million worth CRISPR Pact with Jennifer Doudna Co-founded Gene Editing Firm
2021-10-26
Trials & Approvals Cancer
AstraZeneca’s Imfinzi Beats Standard of Care in Advanced Biliary Tract Cancer
2021-10-26
Asia-Pacific Biomanufacturing
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Feature Microbiome
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Trials & Approvals Dupixent
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
1 … 112 113 114 115 116 … 220
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top